10月13日 - ** 生物制药公司 Ardelyx ARDX.O 股价上涨 1.93%，至 5.03 美元
** 公司任命 Sue Hohenleitner 为首席财务官，11 月 4 日生效
** Hohenleitner最近担任强生创新医学北美公司副总裁兼首席财务官
** 现任首席财务官 Justin Renz 将继续留任，直至公司提交第三季度 10-Q 文件。
** 截至目前，该公司股价已下跌约 1%，其中包括本交易日的走势
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.